DWEB-CMS2B
About Mercy

HIPEC Surgical Procedure

Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an advanced and extensive surgical procedure combined with a one-time treatment with heated chemotherapy at the end of the operation. Only a very selected group of patients suffering from peritoneal carcinomatosis (cancer spread within the abdominal surface) can undergo this procedure. These typically include some patients with appendiceal cancer, pseudomyxoma peritonei, ovarian cancer, mesothelioma, and colorectal cancer. The procedure is performed in a few hospitals in the USA only.  A patient support website is available.

HIPEC treatment is not widely accepted by the US physician community despite a very good evidence from a prospective randomized trial (Verwaal 2003), and other studies (Elias 2009Franko 2008Glehen 2004). This approach is considered a gold standard in certain European countries, e.g. in France (Elias 2010). Nevertheless, given very poor prognosis of peritoneal carcinomatosis, it is currently considered the best treatment option available and is endorsed by a number of leading American surgical oncologists (Esquivel 2007).

The first HIPEC treatment in the Mercy Medical Center was in December 2008. At the time of this writing the Mercy Medical Center is the only Iowa center offering this therapy. Watch a news report and learn more on the KCCI website.

Resources on HIPEC from Mercy Surgical Oncologists

join The Conversation

  • Facebook
  • twitter
  • Youtube
  • Pinterest
  • Pinterest

make a Gift

Mercy Foundation
making a Difference